News & Analysis

Latest content

Ericsson sues Apple for patent infringement as cross-licence deal expires

Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US

18 January 2022

Ten things to know about patent litigation in the Central District of California

Docket Navigator data shows the nation’s fourth-busiest patent venue is less defendant-friendly than its neighbour to the north

17 January 2022

Draft Biden SEP policy favours implementers, but even they may still flock to other jurisdictions

Finnegan attorneys Erik Puknys and Michelle Rice explain that while the proposed DOJ/NIST/USPTO FRAND framework is good for implementers, it may not be enough to make the US stand out in global forum competition

17 January 2022

IAM Strategy 300 experts share deals market outlooks for 2022

A 'bear trap' in China, ongoing US validity woes and big M&A opportunities around established brands and IP are among trends highlighted by practitioners

17 January 2022

A brand new IAM; Big names join VVC pool; IBM almost loses US patent crown; Panasonic does Samsung and Signify deals; Sonos decks Google at the ITC; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

16 January 2022

The Western District of Texas is a problem, but not for the reasons you think

Saturday Opinion: the popularity of Judge Alan Albright’s court as a venue for plaintiffs in patent cases comes down to so many of them not feeling they have a fair chance elsewhere

15 January 2022

Without injunctions, the US patent system is rigged in favour of deep pocket defendants

Sonos’s recent win over Google at the ITC demonstrates the importance of innovators having the ability to exclude infringers from practising on their inventions

14 January 2022

Skinny label concerns persist for generics, despite good news from Delaware

A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs

14 January 2022

Welcome to the new-look IAM platform

Redesigned platform launched today allows subscribers to get the most out of our offering, with easy access to up-to-date intelligence, data and insights – plus our deep archive of IP value creation coverage

14 January 2022

IBM comes very close to losing its US patent leadership crown

Kyndryl spin-out saw Samsung get within 24 grants of taking the top slot from Big Blue in 2021

13 January 2022

Get unlimited access to all IAM content